All 1 tracked stories fall under one category: market-trends. LifeStance Health Group is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 4 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Dole
All 1 tracked stories fall under one category: market-trends. LifeStance Health Group is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 4 for the broader beat in this window. At 5, the average consequence score sits below the same-window beat average of 5.7. Dole appears in 1 tracked Healthcare story from February 25, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 31 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Dole. Shared-story counts are live from our verified record — not editorial picks.
LifeStance Health Group reported its fourth-quarter results for 2025, concurrently issuing a strategic financial outlook for fiscal year 2026. The company is pivoting from aggressive footprint expansion toward margin optimization and clinician retention as it targets long-term profitability.